Literature DB >> 22805517

Cystatin C, creatinine, and albuminuria: bringing risk into 3 dimensions.

Joseph A Abdelmalek, Dena E Rifkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22805517      PMCID： PMC4136753          DOI： 10.1053/j.ajkd.2012.05.003

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  23 in total

1.  Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Salman Waheed; Kunihiro Matsushita; Yingying Sang; Ron Hoogeveen; Christie Ballantyne; Josef Coresh; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2012-04-25       Impact factor: 8.860

2.  Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Authors:  Carmen A Peralta; Michael G Shlipak; Suzanne Judd; Mary Cushman; William McClellan; Neil A Zakai; Monika M Safford; Xiao Zhang; Paul Muntner; David Warnock
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

3.  Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.

Authors:  Andy Choi; Rebecca Scherzer; Peter Bacchetti; Phyllis C Tien; Michael S Saag; Cynthia L Gibert; Lynda A Szczech; Carl Grunfeld; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

4.  Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.

Authors:  Wolfgang Koenig; Dorothee Twardella; Hermann Brenner; Dietrich Rothenbacher
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

5.  The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.

Authors:  Elisabet Nerpin; Erik Ingelsson; Ulf Risérus; Johan Sundström; Anders Larsson; Elisabeth Jobs; Magnus Jobs; Stein Hallan; Björn Zethelius; Lars Berglund; Samar Basu; Johan Arnlöv
Journal:  Nephrol Dial Transplant       Date:  2011-02-18       Impact factor: 5.992

6.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

7.  Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate.

Authors:  Massimo Cirillo; Maria Paola Lanti; Alessandro Menotti; Martino Laurenzi; Mario Mancini; Alberto Zanchetti; Natale G De Santo
Journal:  Arch Intern Med       Date:  2008-03-24

8.  Cystatin C as a risk factor for outcomes in chronic kidney disease.

Authors:  Vandana Menon; Michael G Shlipak; Xuelei Wang; Josef Coresh; Tom Greene; Lesley Stevens; John W Kusek; Gerald J Beck; Allan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

9.  Cystatin C identifies chronic kidney disease patients at higher risk for complications.

Authors:  Carmen A Peralta; Ronit Katz; Mark J Sarnak; Joachim Ix; Linda F Fried; Ian De Boer; Walter Palmas; David Siscovick; Andrew S Levey; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 14.978

10.  Cystatin C, albuminuria, and mortality among older adults with diabetes.

Authors:  Ian H de Boer; Ronit Katz; Jie J Cao; Linda F Fried; Bryan Kestenbaum; Ken Mukamal; Dena E Rifkin; Mark J Sarnak; Michael G Shlipak; David S Siscovick
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 19.112
View more
  1 in total

1.  Markers of kidney function, genetic variation related to cognitive function, and cognitive performance in the UK Biobank.

Authors:  Erin L Richard; Linda K McEvoy; Ian J Deary; Gail Davies; Steven Y Cao; Eyal Oren; John E Alcaraz; Andrea Z LaCroix; Jan Bressler; Rany M Salem
Journal:  BMC Nephrol       Date:  2022-04-27       Impact factor: 2.585
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.